Emerging Peptide Therapeutics for Inflammatory Autoimmune Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|9|1136-1142

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.9, 2010-03, pp. : 1136-1142

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging Peptide Therapeutics for Inflammatory Diseases

By  

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 4, 2006-08 ,pp. : 241-246

Bentham Science Publishers

Access to resources Recommend Favorite

Genomics and the Prospects of Existing and Emerging Therapeutics for Cardiovascular Diseases

By  

Current Pharmaceutical Design, Vol. 15, Iss. 27, 2009-09 ,pp. : 3193-3206

Bentham Science Publishers

Access to resources Recommend Favorite

Th22 and related cytokines in inflammatory and autoimmune diseases

By Tian Tian   Yu Shuang   Ma Daoxin  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 2, 2013-02 ,pp. : 113-125

Informa Healthcare

Access to resources Recommend Favorite

Interleukin-25: Key Regulator of Inflammatory and Autoimmune Diseases

By  

Current Pharmaceutical Design, Vol. 17, Iss. 34, 2011-11 ,pp. : 3781-3785

Bentham Science Publishers

Access to resources Recommend Favorite

IL-19 as a Potential Therapeutic in Autoimmune and Inflammatory Diseases

By  

Current Pharmaceutical Design, Vol. 17, Iss. 34, 2011-11 ,pp. : 3776-3780

Bentham Science Publishers

Access to resources Recommend Favorite